St. Judes wins CE Mark for next-gen heart defibrillators

05/13/2013 | MedGadget.com

St. Jude Medical received the CE mark for its Ellipse and SJM Assura suite of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The next-generation devices are used to administer high-voltage electricity to heart tissue and come with advanced coating to help lower the risk for electrode lead abrasion.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX